Lisata Therapeutics, Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on LSTA yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Lisata Therapeutics filed an amended 8-K listing financial statements and exhibits under Item 9.01. The headline and teaser give no detail on what the financial statements contain.
Lisata Therapeutics announced a one-for-fifteen reverse stock split of its common stock. Holders would own fewer shares at a proportionally higher price, which is a housekeeping step that can affect share count and trading per share.
Lisata Therapeutics filed an 8-K reporting material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws, plus other events. The filing's details are not in the headline or teaser, so the specific changes for shareholders are unclear.
Lisata Therapeutics announced a one-for-fifteen reverse stock split of its common stock, with split-adjusted trading on Nasdaq starting at the November 23, 2026 open under the same LSTA symbol. The company also gave a new CUSIP for the shares.
No SEC financials for LSTA yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.